Autobahn Therapeutics

1 follower


Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body.

Employees

11-50

Links

Org chart

Kevin Finney
Chairman And CEO

Kevin Finney

Collapse
Gudarz Davar
Evp, Head Of Research And Development, CMO
John Borkholder
General Counsel & SVP, Administration
Betsy Vaughn
Vice President, Talent And Culture
Alida Barry, RAC
Vice President, Head Of Regulatory Affairs
Chan Beals
SVP Translational Medicine
Nancy Brzezniak
Sr. Director Finance & Controller
Jason Harris
Vp, Head Of Preclinical Research

Board & advisors

Ben Cravatt
Director
Keith Lenden
Senior Advisor
Tom Scanlan
Scientific Advisor
Bruce Cree
Scientific Advisor
Edmund Harrigan
Scientific Advisor
Maurizio Fava
Scientific Advisor
Robert Conley
Scientific Advisor
Ellis F. Unger
Scientific Advisor